nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A home-based exercise programme attenuates fatigue in primary biliary cholangitis: Results from the EXCITED clinical trial
|
Freer, Alice |
|
|
6 |
12 |
p. |
artikel |
2 |
Contents
|
|
|
|
6 |
12 |
p. |
artikel |
3 |
Copyright and information
|
|
|
|
6 |
12 |
p. |
artikel |
4 |
Corrigendum to: ‘Gut Bifidobacterium longum is associated with better native liver survival in patients with biliary atresia’ (JHEP Reports, Volume 6, Issue 7, July 2024, 101090)
|
Lee, Chee-Seng |
|
|
6 |
12 |
p. |
artikel |
5 |
Development of mutated β-catenin gene signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC
|
Lehrich, Brandon M. |
|
|
6 |
12 |
p. |
artikel |
6 |
Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD
|
Pustjens, Jesse |
|
|
6 |
12 |
p. |
artikel |
7 |
Editorial Board page
|
|
|
|
6 |
12 |
p. |
artikel |
8 |
Essential roles of B cell subsets in the progression of MASLD and HCC
|
Petriv, Nataliia |
|
|
6 |
12 |
p. |
artikel |
9 |
Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis
|
Chan, Connie |
|
|
6 |
12 |
p. |
artikel |
10 |
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study
|
Perez-Campuzano, Valeria |
|
|
6 |
12 |
p. |
artikel |
11 |
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
|
Carli, Fabrizia |
|
|
6 |
12 |
p. |
artikel |
12 |
Mechanisms and implications of recompensation in cirrhosis
|
Piano, Salvatore |
|
|
6 |
12 |
p. |
artikel |
13 |
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals
|
Semmler, Georg |
|
|
6 |
12 |
p. |
artikel |
14 |
Molecular imaging of macrophage composition and dynamics in MASLD
|
Yang, Bin Q. |
|
|
6 |
12 |
p. |
artikel |
15 |
Real-world experience with long-term albumin in patients with cirrhosis and ascites
|
Pompili, Enrico |
|
|
6 |
12 |
p. |
artikel |
16 |
Reply to: “Unlocking hope: HCV re-treatment strategy for patients with active hepatocellular carcinoma”
|
Graf, Christiana |
|
|
6 |
12 |
p. |
artikel |
17 |
Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screening
|
Qureshi, Ayesha A. |
|
|
6 |
12 |
p. |
artikel |
18 |
Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024
|
Žigutytė, Laura |
|
|
6 |
12 |
p. |
artikel |